The Department of Pharmaceutical Sciences presents seminar speaker, Dr. Sudhakar Garad.
Seminar title “Understanding Developability Assessment of Small Molecules During Research”
Wednesday, March 4th, 2020, from 3:30 – 4:30 in Pharmacy/Biology Building (PBB) room 129.
Dr. Garad is Global head of Chemical and Pharmaceutical Profiling and Disease Area Head (New Indications) at Novartis Institutes for Biomedical Research.
His primary role is to collaborate with research colleagues and build the right biopharmaceutical properties into new chemical entities, if not enable them via solubility/dissolution enhancement technologies to expedite molecules into tox and clinical studies. He is also responsible for enabling research, clinical and commercial molecules via novel delivery technologies (Brain targeting, permeability enhancement, TI improvement etc). In the last 20 years of his career he has taken more than 200 new chemical entities in clinical studies across dozen disease areas ( CVM, Oncology, ATI, MS, Respiratory, NS, GI, Antibacterial, Tropical diseases, HCV etc), via oral, parenteral, inhalation and transdermal route of administration.
For more information, contact: Dr. Robin Bogner at 860.486.2136